Weight Loss News and Research

Latest Weight Loss News and Research

Group weight loss programs reduce risk for type 2 diabetes

The 57 million Americans currently living with "pre-diabetes" could benefit from a group weight loss program, like Weight Watchers, according to a new study published in this month's American Journal of Lifestyle Medicine. Researchers found that after a 6-month Weight Watchers group program, overweight or obese adults who attended at least two thirds of the weekly sessions, not only lost weight, but also significantly reduced fasting glucose and insulin levels - important indicators of diabetes risk.

21 May 2010

Weight Watchers group program helps obese adults lose weight, reduce glucose and insulin levels

20 May 2010

Work stress, economic pressures contribute to weight gain among U.S. labor force: Survey

The combination of work stress and economic pressures appears to be playing a role in the U.S. labor force's weight gain. Overall, 44 percent of workers say they have gained weight in their current jobs, up slightly from 43 percent in 2009, according to a new CareerBuilder survey. Nearly one-third (32 percent) of workers say that stress contributed to their weight gain at work.

19 May 2010

Low blood phosphorus levels associated with high death rates in African AIDS patients: Research

Low blood phosphorus levels are associated with high death rates in the initial weeks of antiretroviral therapy (ART) in AIDS patients in sub-Saharan Africa, according to new research conducted by University of Alabama at Birmingham researchers at the UAB-affiliated Centre for Infectious Disease Research in Zambia.

19 May 2010

China Sky One Medical first-quarter total revenues increase 16.4% to $28.9 million

China Sky One Medical, Inc., a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China, today announced record financial results for the first quarter of 2010. Management is working diligently to finalize the amended Annual Report on Form 10-K for 2009.

18 May 2010

Is gluten the latest villain in the battle for better health?

If you've been food shopping or out to eat lately, you've probably noticed that "gluten-free" foods now claim their own grocery store shelves and dozens of national restaurant chain menus highlight "gluten-free" entrees.

17 May 2010

Obese patients with COPD improve following pulmonary rehabilitation program: Research

Obese patients with chronic obstructive pulmonary disease stand to gain as much from pulmonary rehabilitation as their slimmer counterparts, even though as a group they have a lower exercise capacity, according to new research from the University Hospitals of Leicester in the UK.

17 May 2010

Interleukin Genetics reports 166% increase in overall genetic test revenue for first-quarter 2010

Interleukin Genetics, Inc. announced today financial and operational results for the first quarter ended March 31, 2010.

14 May 2010

Nationwide Children's Hospital offers new gastric sleeve surgical weight loss procedure

A new weight reduction surgical option is now available through the Center for Healthy Weight and Nutrition at Nationwide Children's Hospital. The newest surgical weight loss procedure offered by the Center is the "gastric sleeve," named as such because a large part of the stomach is removed and the remainder is closed to make a tube-like "sleeve."

14 May 2010

Data on Qnexa to be presented at World Congress on CODHy in Prague

VIVUS, Inc. today announced that data on Qnexa, an investigational drug candidate, will be presented at the 3rd World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension in Prague, Czech Republic.

13 May 2010

Transition Therapeutics reports increased revenue in third-quarter 2010

Transition Therapeutics Inc., a product-focused biopharmaceutical company developing therapeutics for disease indications with large markets, today announced its financial results for the quarter ended March 31, 2010.

11 May 2010

Orexigen Therapeutics first-quarter net loss decreases to $14.1 million

Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the first quarter of 2010. For the quarter ended March 31, 2010, Orexigen reported a net loss of $14.1 million, or $0.30 per share attributable to common stockholders, as compared to a net loss of $19.3 million, or $0.56 per share attributable to common stockholders, for the first quarter of 2009.

11 May 2010

Genetic link to risk for diabetes and weight gain: New study

A recent study published in the international journal Diabetologia showed that Australians who eat too many high fat snacks tend to put on more weight if they have someone in their family with diabetes.

10 May 2010

Inflammation enzyme regulates production of brown fat tissue

Love handles, muffin tops and stomach tires - white fat tissue forms the typical curves in the notorious problem areas to store energy. Exactly the opposite happens in brown fat tissue: Instead of being stored, energy gets transformed into heat. To the dismay of many people, adults have only small amounts of this energy burner. By contrast, babies and animals in hibernation have lots of it in their bodies where it serves for heat regulation.

7 May 2010

Arena Pharmaceuticals reports lower net loss of $31.3 million in first-quarter 2010

Arena Pharmaceuticals, Inc. today reported financial results for the first quarter ended March 31, 2010.

7 May 2010

Methane in breath linked to obesity

New Cedars-Sinai research shows obese patients who test positive for methane on their breath have a significantly higher body mass index (BMI) than their peers.

7 May 2010

Weight Watchers reports 4.9% decrease in first-quarter 2010 revenue

Weight Watchers International, Inc. today announced its results for the first quarter of fiscal 2010, which ended April 3, 2010, and reaffirmed its fiscal 2010 earnings guidance.

7 May 2010

FDA assigns BYDUREON new PDUFA action date of October 22, 2010

Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced that the U.S. Food and Drug Administration (FDA) has classified the BYDUREON™ (exenatide for extended-release injectable suspension) complete response as a Class 2 resubmission and assigned a new Prescription Drug User Fee Act (PDUFA) action date of October 22, 2010.

6 May 2010

Study reveals long-term advantages of fast initial weight loss

If you thought the best way to lose and maintain weight was the slow and steady approach, think again. A new study by Lisa Nackers and colleagues, from the University of Florida in the US, suggests that the key to long-term weight loss and maintenance is to lose weight quickly, not gradually, in the initial stages of obesity treatment. Their findings1 are published online in Springer's International Journal of Behavioral Medicine.

6 May 2010

Obesity epidemic may be flattening out - still much to be done

The prevalence of childhood obesity might be stabilising in developed countries, but there is still much to be done to combat this major threat to health, according to a Seminar published on Online First and in an upcoming issue of The Lancet.

6 May 2010

Weight Loss News and Research

Latest Weight Loss News and Research

Group weight loss programs reduce risk for type 2 diabetes

Weight Watchers group program helps obese adults lose weight, reduce glucose and insulin levels

Work stress, economic pressures contribute to weight gain among U.S. labor force: Survey

Low blood phosphorus levels associated with high death rates in African AIDS patients: Research

China Sky One Medical first-quarter total revenues increase 16.4% to $28.9 million

Is gluten the latest villain in the battle for better health?

Obese patients with COPD improve following pulmonary rehabilitation program: Research

Interleukin Genetics reports 166% increase in overall genetic test revenue for first-quarter 2010

Nationwide Children's Hospital offers new gastric sleeve surgical weight loss procedure

Data on Qnexa to be presented at World Congress on CODHy in Prague

Transition Therapeutics reports increased revenue in third-quarter 2010

Orexigen Therapeutics first-quarter net loss decreases to $14.1 million

Genetic link to risk for diabetes and weight gain: New study

Inflammation enzyme regulates production of brown fat tissue

Arena Pharmaceuticals reports lower net loss of $31.3 million in first-quarter 2010

Methane in breath linked to obesity

Weight Watchers reports 4.9% decrease in first-quarter 2010 revenue

FDA assigns BYDUREON new PDUFA action date of October 22, 2010

Study reveals long-term advantages of fast initial weight loss

Obesity epidemic may be flattening out - still much to be done

Pharmaceutical Manufacturing - Industry Focus eBook eBook

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Weight Loss News and Research

Latest Weight Loss News and Research

Pharmaceutical Manufacturing - Industry Focus eBook eBook

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Newsletters you may be interested in